Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Additionele inductiechemotherapie leidt niet tot betere uitkomsten bij hoogrisico neuroblastoom
mei 2020 | Neuro-oncologie